Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is the most common form of irreversible blindness in developed countries. Variants in the factor H gene (CFH, also known as HF1), which encodes a major inhibitor of the alternative complement pathway, are associated with the risk for developing AMD. Here we test the hypothesis that variation in genes encoding other regulatory proteins of the same pathway is associated with AMD. We screened factor B (BF) and complement component 2 (C2) genes, located in the major histocompatibility complex class III region, for genetic variation in two independent cohorts comprising approximately 900 individuals with AMD and approximately 400 matched controls. Haplotype analyses identify a statistically significant common risk haplotype (H1) and two protective haplotypes. The L9H variant of BF and the E318D variant of C2 (H10), as well as a variant in intron 10 of C2 and the R32Q variant of BF (H7), confer a significantly reduced risk of AMD (odds ratio = 0.45 and 0.36, respectively). Combined analysis of the C2 and BF haplotypes and CFH variants shows that variation in the two loci can predict the clinical outcome in 74% of the affected individuals and 56% of the controls. These data expand and refine our understanding of the genetic risk for AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This analysis resulted in the identification of the previously well documented independently associated variants near CFH and C2/CFB8,10,31,32 and of additional independent signals near C3, CETP, LIPC, FRK/COL10A1, IER3/DDR1, RAD51B (Supplementary Table 6).”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“These include complement 2 (C2) and/or complement factor B (CFB) (56), complement 3 (C3) (170), and complement factor I (CFI) (44).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [56]
In the citing paper
“studies have demonstrated that at least one of the two variants associated with AMD—R32Q BF—leads to an impairment in the complement activating function of BF (Gold et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
In the citing paper
“the L9H BF/E318D C2 and R32Q BF/intronic variants of C2 have been shown to be protective for AMD (odds ratio (OR) = 0.45 and 0.36, respectively) by Gold et al.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Overall type I error rates (α) were retrospectively calculated using a previously described metho”
MethodComplement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Self-citationBird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Self-citationDrusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome
Myers, S., Bottolo, L., Freeman, C., McVean, G., & Donnelly, P. (2005) · Science · doi:10.1126/science.1117196 · Cited by 1,134 · cited 1×
“Fourth, estimated recombination rates from HapMap data indicate regions of high recombination on both sides of the C2/BF locu”
BackgroundA role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citation
Cited by
Items 501–600 of 1,000
Genotypic Influences on Severity of Exudative Age-Related Macular Degeneration
Leveziel, N., Puche, N., Richard, F., Somner, J., Zerbib, J., Bastuji‐Garin, S., Cohen, S. Y., Korobelnik, J., Sahel, J., Soubrane, G., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4423 · Cited by 35
Saddala, M. S., Lennikov, A., Mukwaya, A., Fan, L., Hu, Z., & Hu, H. (2019) · Human Genomics · doi:10.1186/s40246-019-0199-1 · Cited by 36
“These genes are in tandem in the major histocompatibility complex class III region, a cluster of immune-related genes on chromosome 6p and that carry AMD risk [41].”
Two genetic pathways for age-related macular degeneration
DeWan, A. T., Bracken, M. B., & Hoh, J. J. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.04.004 · Cited by 38
A Clinician's View of the Molecular Genetics of Age-Related Maculopathy
Gorin, M. B. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.1.21 · Cited by 36
Update on the role of genetics in the onset of age-related macular degeneration
Francis, P. J., & Klein, M. L. (2011) · Clinical ophthalmology · doi:10.2147/opth.s11627 · Cited by 39
“33,37 Subsequent analyses of the complement pathway identified SNPs in other complement components: complement factors C2 , CFB , 38,39 C3 , 40,41 and CFI.”
Demirs, J. T., Yang, J., Crowley, M. A., Twarog, M., Delgado, O., Qiu, Y., Poor, S. H., Rice, D. S., Dryja, T. P., Anderson, K., et al. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.7.26 · Cited by 35
Recent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review
Finocchio, L., Zeppieri, M., Gabai, A., Toneatto, G., Spadea, L., & Salati, C. (2023) · Biomedicines · doi:10.3390/biomedicines11123221 · Cited by 34
New era for personalized medicine: the diagnosis and management of age‐related macular degeneration
Baird, P. N., Hageman, G. S., & Guymer, R. H. (2009) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2009.02136.x · Cited by 35
“These genes account for a substantial proportion of the genetic predisposition associated with the disease.(10,12,19,21) Of the genes thus far identified, a majority play roles in the immune/inflammatory system.”
BackgroundSelf-citationIncreased Vitronectin Production by Complement-Stimulated Human Retinal Pigment Epithelial Cells
Wasmuth, S., Lueck, K., Baehler, H., Lommatzsch, A. P., & Pauleikhoff, D. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3326 · Cited by 36
Development of gene therapy for treatment of age‐related macular degeneration
Askou, A. L. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12452 · Cited by 35
“2002) as well as genetic studies revealing a highly significant association between AMD and variants of several complement pathway-associated genes (Fig. 5, purple box; Majewski et al. 2003; Fisher et al. 2005; Gold et al. 2006; Thakkinstian et al. 2006; Maller et al. 2007; Yates et al. 2007; Spencer et al. 2008; Fran…”
BackgroundInfluentialGenetic risk factors and age-related macular degeneration (AMD)
Mousavi, M., & Armstrong, R. A. (2013) · Journal of Optometry · doi:10.1016/j.optom.2013.07.002 · Cited by 34
“Genetic variants of the serpin peptidase inhibitor (SERP-ING1 ) gene, which regulates the activity of complement proteins, have recently been shown to be associated with AMD 23 ; the protein inhibits the first components of the complement cascade and thus regulates complement activation.”
Graßmann, F., Cantsilieris, S., Schulz-Kuhnt, A.-S., White, S. J., Richardson, A. J., Hewitt, A. W., Vote, B. J. T., Schmied, D., Guymer, R. H., Weber, B. H. F., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0548-0 · Cited by 35
“The C4 gene is located on chromosome 6p21 in the MHC class III region around 30 kb proximal to the CFB/C2 locus known to be strongly associated with AMD [5, 38].”
BackgroundRohrer, B., Long, Q., Coughlin, B. A., Renner, B., Huang, Y. J., Kunchithapautham, K., Ferreira, V. P., Pangburn, M. K., Gilkeson, G. S., Thurman, J. M., et al. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_10 · Cited by 35
Lederman, M., Weiss, A. T., & Chowers, I. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3019 · Cited by 33
Sobrin, L., Maller, J. B., Neale, B. M., Reynolds, R. C., Fagerness, J. A., Daly, M. J., & Seddon, J. M. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.185 · Cited by 31
The complement system and diabetic retinopathy
Jiang, F., Lei, C., Chen, Y., Zhou, N., & Zhang, M. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.02.004 · Cited by 42
Genetic Insights into Age-Related Macular Degeneration
Bhumika, Bora, N. S., & Bora, P. S. (2024) · Biomedicines · doi:10.3390/biomedicines12071479 · Cited by 35
“CFB and C2, essential activators within the complement system pathway, are closely related genes positioned at a difference of 500 base pairs on the 6p21 locus in humans [66].”
BackgroundGenetic Susceptibility, Diet Quality, and Two-Step Progression in Drusen Size
Merle, B. M. J., ROSNER, B. A., & Seddon, J. M. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.5.17 · Cited by 32
“27,38 Other than CFH and C3 , the other genetic variant most significantly associated with drusen growth is the common variant in the gene locus ARMS2/HTRA1 .”
Khan, A. H., Pierce, C., Salvo, G. D., Griffiths, H., Nelson, M., Cree, A. J., Menon, G., & Lotery, A. J. (2021) · Eye · doi:10.1038/s41433-021-01824-3 · Cited by 33
Complement Factor H Autoantibodies and Age-Related Macular Degeneration
Dhillon, B., Wright, A. F., Tufail, A., Pappworth, I., Hayward, C., Moore, I., Strain, L., Kavanagh, D., Barlow, P. N., Herbert, A. P., et al. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-5124 · Cited by 30
Gene Transfer for Neovascular Age-Related Macular Degeneration
Campochiaro, P. A. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.050 · Cited by 31
“Genetic studies have suggested that complement-mediated damage plays a role in susceptibility to AMD (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005; Gold et al., 2006), but exactly how it plays a role is unknown.”
BackgroundProitsi, P., Lupton, M. K., Dudbridge, F., Tsolaki, M., Hamilton, G., Daniilidou, M., Pritchard, M., Lord, K., Martin, B. M., Craig, D., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.036 · Cited by 38
“protective alleles has been reported in 74% of AMD cases (Gold et al., 2006; Maller et al., 2006).”
BackgroundGenetic factors associated with the development of age-related macular degeneration
Sergejeva, O., Botov, R., Liutkevičienė, R., & Kriaučiūnienė, L. (2016) · Medicina · doi:10.1016/j.medici.2016.02.004 · Cited by 37
Novel Retinal and Cone Photoreceptor Transcripts Revealed by Human Macular Expression Profiling
Hornan, D., Peirson, S. N., Hardcastle, A. J., Molday, R. S., Cheetham, M. E., & Webster, A. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0355 · Cited by 32
“It is the most common cause of blindness in the developed world and is responsible for more than 50% of blind or partial sight registrations in the UK.4 Approximately 10% of people older than 65 and 30% older than 75 show retinal changes consistent with AMD.”
BackgroundInfluentialThe Immunological Basis of Degenerative Diseases of the Eye
Nussenblatt, R. B., Liu, B., Wei, L., & Sen, H. N. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2012.740536 · Cited by 35
“DNA variants in numerous genes have been associated with AMD [30], including complement factor H (CFH) gene [31–35], CFB [36], complement 2 [36], complement 3 (C3) [37], complement factor I (CFI) [It would be useful to provide a table with relative risk factors for these genes here 38], the ARMS2/HTRA1 region [39–44],…”
BackgroundChang, B., Mandal, M. N. A., Chavali, V. R. M., Hawes, N. L., Khan, N. W., Hurd, R. E., Smith, R. S., Davisson, M. L., Kopplin, L., Klein, B. E. K., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn295 · Cited by 30
Self-citationLee, A., Kulkarni, M., Fang, A. M., Edelstein, S., Osborn, M. P., & Brantley, M. A. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.172007 · Cited by 30
“In light of recent findings, it appears that SERPING1 has a modest effect on the risk of neovascular AMD and should be included in the growing list of genes that may be associated with AMD.”
BackgroundInfluentialConnolly, E., Rhatigan, M., O’Halloran, A. M., Muldrew, K. A., Chakravarthy, U., Cahill, M. T., Kenny, R. A., & Doyle, S. (2018) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2017-311673 · Cited by 35
Age-related Macular Degeneration (AMD): A Review on its Epidemiology and Risk Factors
Salimiaghdam, N., Riazi-Esfahani, M., Fukuhara, P. S., Schneider, K., & Kenney, M. C. (2019) · The Open Ophthalmology Journal · doi:10.2174/1874364101913010090 · Cited by 34
Biomarkers as Predictive Factors of Anti-VEGF Response
Bobadilla, M., Pariente, A., Ana, I., Peláez, R., Pérez-Sala, Á., & Larráyoz, I. M. (2022) · Biomedicines · doi:10.3390/biomedicines10051003 · Cited by 33
Wu, L., Tao, Q., Chen, W., Wang, Z., Song, Y., Sheng, S.-Y., Li, P., & Zhou, J. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10453 · Cited by 30
Sofat, R., Casas, J. P., Kumari, M., Talmud, P. J., Ireland, H., Kivimäki, M., Marmot, M. G., Hughes, A. D., Thom, S., Ebrahim, S. B. J., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.07.021 · Cited by 32
“Other genes in the complement pathway, including those encoding factor B and C3, have also been implicated in AMD [12,13].”
BackgroundSong, D., Sulewski, M. E., Wang, C., Song, J., Bhuyan, R., Sterling, J. K., Clark, E., Song, W.-C., & Dunaief, J. L. (2017) · PubMed Central · Cited by 34
Lu, F., Liu, S., Hao, Q.-Y., Liu, L., Zhang, J., Chen, X., Wang, H., & Huang, P. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2018.0110 · Cited by 34
“Among these, 49 were case–control studies and 4 were cohort studies (Gold et al. , 2006; Gotoh et al. , 2006; Li et al. , 2006; Maller et al. , 2006; Mori et al. , 2007; Spencer et al. , 2007, 2008; Yates et al. , 2007; Chu et al. , 2008; Edwards et al. , 2008; Jakobsdottir et al. , 2008; Ng et al.…”
The SERPING1 gene and age-related macular degeneration
Allikmets, R. L., Dean, M. C., Hageman, G. S., Baird, P. N., Klaver, C. C. W., Bergen, A. A. B., & Weber, B. H. F. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61618-4 · Cited by 30
Self-citationFrudd, K., Sivaprasad, S., Raman, R., Krishnakumar, S., Revathy, Y. R., & Turowski, P. (2021) · Acta Ophthalmologica · doi:10.1111/aos.14954 · Cited by 36
“Additional polymorphisms in the CFH and CFB genes are also correlated with a higher risk of developing age-related macular degeneration (Gold et al., 2006; Liu et al., 2010), a disorder that shares many pathophysiological features with DR.”
BackgroundFactors determining age-related macular degeneration: a current view
Liutkevičienė, R., Lesauskaitė, V., Ašmonienė, V., Žaliūnienė, D., & Jašinskas, V. (2010) · Medicina · doi:10.3390/medicina46020013 · Cited by 34
Lechanteur, Y. T. E., van de Ven, J. P. H., Smailhodzic, D., Boon, C. J. F., Klevering, B. J., Fauser, S., Groenewoud, J. M. M., van der Wilt, G. J., den Hollander, A. I., & Hoyng, C. B. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7731 · Cited by 36
Sun, C., Zhao, M., & Li, X. (2012) · Current Eye Research · doi:10.3109/02713683.2011.635401 · Cited by 32
Seitzman, R. L., Mahajan, V. B., Mangione, C. M., Cauley, J. A., Ensrud, K. E., Stone, K. L., Cummings, S. R., Hochberg, M. C., Hillier, T. A., Sinsheimer, J. S., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn024 · Cited by 35
“Recent research has shown common variants in the complement factor H (4–7), LOC38775 (8, 9), HtrA serine peptidase 1 (10, 11), complement component 2 (12), and complement factor B (12) genes to be strongly associated with ARM.”
BackgroundMerle, B. M. J., Richard, F., Benlian, P., Puche, N., Delcourt, C., & Souied, E. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0130816 · Cited by 29
Hautamäki, A., Seitsonen, S., Holopainen, J. M., Moilanen, J., Kivioja, J. L., Onkamo, P., Järvelä, I. E., & Immonen, I. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12799 · Cited by 33
“…association studies have emphasized the role of individual variations in the alternative complement cascade in increasing the risk of AMD development (Edwards et al. 2005; Haines et al. 2005; Klein et al. 2005; Gold et al. 2006; Maller et al. 2006, 2007; Yates et al. 2007; Seddon et al. 2013).”
BackgroundLechanteur, Y. T. E., van de Camp, P., Smailhodzic, D., van de Ven, J. P. H., Buitendijk, G. H. S., Klaver, C. C. W., Groenewoud, J. M. M., den Hollander, A. I., Hoyng, C. B., & Klevering, B. J. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.18 · Cited by 33
Analysis of candidate genes for macular telangiectasia type 2.
Parmalee, N. L., Schubert, C., Merriam, J. E., Allikmets, K., Bird, A. C., Gillies, M. C., Pető, T., Figueroa, M. J., Friedlander, M., Fruttiger, M., et al. (2010) · PubMed Central · Cited by 29
Self-citationThe ERCC6 Gene and Age-Related Macular Degeneration
Baas, D. C., Despriet, D. D. G., Gorgels, T. G. M. F., Sawitzke, J., Uitterlinden, A. G., Hofman, A., van Duijn, C. M., Merriam, J. E., Smith, R. T., Barile, G. R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013786 · Cited by 31
“Recently, associations with AMD were also found for other genes of the complement cascade (complement factor B, C2, C3) [11-13], but, interestingly enough, not for C5, although it should be noted that only relatively common SNPs in C5 were screened [14].”
BackgroundSelf-citationSardell, R. J., Persad, P. J., Pan, S. S., Whitehead, P. G., Adams, L. D., Laux, R. A., Fortun, J. A., Brantley, M. A., Kovach, J. L., Schwartz, S. G., et al. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19519 · Cited by 31
“We also tested the three additional variants in these regions that were tested for effects on AMD progression previously,(24,25,30,31) thereby allowing comparison between studies: the independently associated nonsynonymous CFH:rs1061170 (Y402H) polymorphism and two protective variants in the C2-CFB region (C2:rs933273…”
Genetic Association of Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
Chen, L. J. (2020) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/01.apo.0000656976.47696.7d · Cited by 29
Jones, R., Ridley, C. E., Jowitt, T. A., Wang, M.-C., Howard, M., Bobola, N., Wang, T., Bishop, P. N., Kielty, C. M., Baldock, C., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4620 · Cited by 28
Kim, S. J., Lee, S., Kim, N. R., & Chin, H. S. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.01.005 · Cited by 30
“After the discovery of CFH, a series of other genes involved in AMD pathogenesis were discovered in the complement pathway and in chronic inflammation, such as complement component 2 (C2)/complement factor B (CFB) (Gold et al., 2006; McKay et al., 2009) and complement component 3 (C3) (Yates et al.”
BackgroundResultInfluentialEmerging therapeutic approaches in the management of retinal angiogenesis and edema
Truong, A., Wong, T. Y., & Khachigian, L. M. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0709-z · Cited by 30
“Reports in the last 5 years have revealed a probable association between the development of AMD and the complement pathway [86–90].”
BackgroundA genetic approach to stratification of risk for age-related macular degeneration
Zanke, B. W., Hawken, S., Carter, R., & Chow, D. R. (2010) · Canadian Journal of Ophthalmology · doi:10.3129/i09-209 · Cited by 31
Genetic variation in complement regulators and susceptibility to age-related macular degeneration
Cipriani, V., Matharu, B. K., Khan, J. C., Shahid, H., Stanton, C. M., Hayward, C., Wright, A. F., Bunce, C., Clayton, D. G., Moore, A. T., et al. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.09.002 · Cited by 28
“There is conclusive vidence that the common expressed variant Y402H (rs1061170) n the CFH gene influences susceptibility to AMD (Klein et al. 2005; aines et al. 2005; Edwards et al. 2005) with heterozygotes and omozygotes for the 402H allele being 2.5 and 6 times more likely o have AMD respectively…”
BackgroundInfluentialRanibizumab for the treatment of degenerative ocular conditions
Panos, G. D., Triantafylla, M., Massa, H. F., Dardabounis, D., Gatzioufas, Z., Kozobolis, V., Ioannakis, K., & Perente, İ. (2014) · Clinical ophthalmology · doi:10.2147/opth.s40350 · Cited by 29
“Elevated levels of VEGF-A have been found in CNV membranes from patients with AMD.”
InfluentialSpencer, K. L., Hauser, M. A., Olson, L. M., Schnetz‐Boutaud, N. C., Scott, W. K., Schmidt, S., Gallins, P. J., Agarwal, A., Postel, E. A., Pericak‐Vance, M. A., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1427 · Cited by 29
EFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration
Cheng, L., Chen, C., Guo, W., Liu, K., Zhao, Q., Lü, P., Yu, F., & Xu, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.547436 · Cited by 28
“…genes (CFH, C2, CFB, CFHR1/ 3, C3, etc.) as well as non-complement-related genes, such as ARMS2 and HTRA1, and lipid metabolism-related loci (Zareparsi et al., 2004; Edwards et al., 2005; Hageman et al., 2005; Gold et al., 2006; Yang et al., 2006; Maller et al., 2007; Fritsche et al., 2016).”
van der Burght, B. W., Hansen, M., Olsen, J., Zhou, J., Wu, Y., Nissen, M. H., & Sparrow, J. R. (2013) · Acta Ophthalmologica · doi:10.1111/aos.12146 · Cited by 26
“Studies implicate the complement cascade as playing an important role in development of AMD (Hageman et al. 2005), and we have previously demonstrated that irradiated A2Eladen RPE cells and photooxidized compounds of A2E can activate the complement cascade (Zhou et al. e541 2006, 2009).”
BackgroundInfluentialInomata, Y., Tanihara, H., Tanito, M., Okuyama, H., Hoshino, Y., Kinumi, T., Kawaji, T., Kondo, N., Yodoi, J., & Nakamura, H. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1659 · Cited by 26
Lin, W., & Lee, W. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-26 · Cited by 27
“(For example, to check whether SNP rs800292 is within 1 Mb from the CFH gene, we simply insert ‘rs800292’ into ‘SNP ID’ and ‘1 Mb’ into the ‘Upstream’ and ‘Downstream’ on the website of GenoWatch [26]: http://genepipe.ngc.sinica.edu.tw/genominer/menu.do) In the end, a total of 639 SNPs were prioritized, and the remain…”
BackgroundInfluentialKato, Y., Oguchi, Y., Omori, T., Shintake, H., Tomita, R., Kasai, A., Ogasawara, M., Sugano, Y., Itagaki, K., Ojima, A., et al. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.13.39 · Cited by 26
Ranibizumab for the treatment of neovascular AMD
Kaiser, P. K., & Diana, V. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01299.x · Cited by 27
Guymer, R. H., & Robman, L. D. (2007) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01392.x · Cited by 28
“Combined analysis of the C2 and BF haplotypes and CFH variant show that together they may predict the clinical outcome in 74% of affected individuals and 56% of controls.(30) The complement cascade is activated by an inciting event or ‘trigger.”
BackgroundInfluentialEpidemiology of Age-Related Macular Degeneration
Seddon, J. M., & Chen, C. A. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02598-0.50064-1 · Cited by 33
Protective Effect of Paraoxonase 1 Gene Variant Gln192Arg in Age-Related Macular Degeneration
Pauer, G. J. T., Sturgill, G. M., Peachey, N. S., & Hagstrom, S. A. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.09.024 · Cited by 26
Yanagisawa, S., Kondo, N., Miki, A., Matsumiya, W., Kusuhara, S., Tsukahara, Y., Honda, S., & Negi, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028847 · Cited by 25
Immunological Aspects of Age-Related Macular Degeneration
Allingham, M. J., Loksztejn, A., Cousins, S. W., & Mettu, P. S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-66014-7_6 · Cited by 26
Gut microbiota and age-related macular degeneration: A growing partnership
Lima-Fontes, M., Meira, L. A. A., Barata, P., Falcão, M. S., & Carneiro, Â. M. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2021.11.009 · Cited by 29
Jawad, S., Liu, B., Li, Z., Katamay, R., Campos, M. M., Wei, L., Sen, H. N., Ling, D., Martínez, F. O., Amaral, J., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11380 · Cited by 26
The Impact of the Human Genome Project on Complex Disease
Bailey, J. N. C., Pericak‐Vance, M. A., & Haines, J. L. (2014) · Genes · doi:10.3390/genes5030518 · Cited by 25
“additional alternative complement pathway activators beyond CFH and determined that variants in complement factor b (BF/CFB) and C2 are highly protective against AMD [54].”
BackgroundTargeting Inflammation in Emerging Therapies for Genetic Retinal Disease
viringipurampeer, I. A., Bashar, E., Gregory, C. Y., Moritz, O. L., & Gregory-Evans, K. (2013) · International Journal of Inflammation · doi:10.1155/2013/581751 · Cited by 30
“Strong associations have been demonstrated for alleles of genes encoding complement factor H (CFH) [24–26] which is a regulator of the alternate complement pathway, complement component C2/complement factor B (C2/CFB) [27], and CFH-related genes CFHR1 and CFHR3 [28].”
BackgroundPositive association of common variants in CD36 with neovascular age-related macular degeneration
Kondo, N., Honda, S., Kuno, S., & Negi, A. (2009) · Aging · doi:10.18632/aging.100006 · Cited by 26
Kondo, N., Honda, S., Kuno, S., & Negi, A. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.03.004 · Cited by 25
The link between morphology and complement in ocular disease
Mohlin, C., Sandholm, K., Ekdahl, K. N., & Nilsson, B. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.05.028 · Cited by 31
Common and rare genetic variants of complement components in human disease
de Jorge, E. G., López‐Lera, A., Bayarri‐Olmos, R., Yébenes, H., López‐Trascasa, M., & de Córdoba, S. R. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.011 · Cited by 28
Mullins, R. F., Faidley, E. A., Daggett, H. T., Jomary, C., Lotery, A. J., & Stone, E. M. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.07.001 · Cited by 29
“This finding has been subsequently replicated by a number of groups, and variations in other genes with products involved in the complement system have also been found to affect AMD risk, including C2 (Gold et al., 2006), complement factor B (Gold et al.”
BackgroundCano, M., Callaway, N. F., Kondo, N., Dike, S., & Handa, J. T. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.010 · Cited by 27
Seitsonen, S., Järvelä, I. E., Meri, S., Tommila, P. V., Ranta, P., & Immonen, I. J. R. (2007) · Acta Ophthalmologica · doi:10.1111/j.1600-0420.2007.01050.x · Cited by 28
“Although several haplotypes and polymorphisms in different genes have been associated with AMD (Hageman et al. 2005; DeWan et al. 2006; Gold et al. 2006; Hughes et al. 2006; Li et al. 2006; Maller et al. 2006; Yang et al. 2006), the CFH Y402H polymorphism is the most thoroughly studied and appears to involve a highly…”
BackgroundDifferentiation of Pluripotent Stem Cells into Retinal Pigmented Epithelium
Croze, R. H., & Clegg, D. (2014) · Developments in ophthalmology · doi:10.1159/000357361 · Cited by 26
Beheshtian, M., Rad, S. S., Babanejad, M., Mohseni, M., Hashemi, H., Eshghabadi, A., Hajizadeh, F., Akbari, M. R., Kahrizi, K., Esfahani, M. R., et al. (2015) · PubMed · Cited by 24
Revisiting immunological and clinical aspects of membranous nephropathy
Nieto-Gañán, I., Iturrieta-Zuazo, I., Rita, C. G., & Carrasco-Sayalero, Á. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.108976 · Cited by 26
Buentello‐Volante, B., Rodriguez-Ruiz, G., Miranda‐Duarte, A., Pompa-Mera, E. N., Graue‐Wiechers, F., Méndez, V. C. B., Ayala-Ramírez, R., Quezada, C., Rodríguez-Loaiza, J. L., & Zenteno, J. C. (2012) · PubMed Central · Cited by 26
Kuo, J. Z.-C., Wong, T. Y., & Ong, F. S.-C. (2013) · Expert Review of Ophthalmology · doi:10.1586/eop.13.3 · Cited by 28
Grossman, T. R., Carrer, M., Shen, L., Johnson, R. B., Hettrick, L. A., Henry, S. P., Monia, B. P., & McCaleb, M. L. (2017) · PubMed Central · Cited by 24
Age-Related Macular Degeneration
Fleckenstein, M., & Holz, F. G. (2014) · Springer eBooks · doi:10.1007/978-3-7091-0715-7_12 · Cited by 24
Narendra, U., Pauer, G. J. T., & Hagstrom, S. A. (2009) · PubMed Central · Cited by 29
Sundaresan, P., Vashist, P., Ravindran, R. D., Shanker, A., Nitsch, D., Nonyane, B. A. S., Smeeth, L. L., Chakravarthy, U., & FLETCHER, A. E. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10073 · Cited by 26
Zhao, L., Wang, Z., Liu, Y., Song, Y., Li, Y., Laties, A. M., & Wen, R. (2007) · PubMed Central · Cited by 29
Reticular macular lesions: a review of the phenotypic hallmarks and their clinical significance
Saade, C., & Smith, R. T. (2014) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12353 · Cited by 23
Self-citationGotoh, N., Yamashiro, K., Nakanishi, H., Saito, M., Iida, T., & Yoshimura, N. (2010) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-010-0865-2 · Cited by 23
THE ARMS2 A69S VARIANT AND BILATERAL ADVANCED AGE-RELATED MACULAR DEGENERATION
Schwartz, S. G., Agarwal, A., Kovach, J. L., Gallins, P. J., Cade, W., Postel, E. A., Wang, G., Ayala-Haedo, J., Spencer, K. M., Haines, J. L., et al. (2012) · Retina · doi:10.1097/iae.0b013e318240a540 · Cited by 26
Zerbib, J., Richard, F., Puche, N., Leveziel, N., Cohen, S. Y., Korobelnik, J., Sahel, J., Münnich, A., Kaplan, J., Rozet, J., et al. (2010) · PubMed Central · Cited by 27
Rohrer, B., Frazer‐Abel, A. A., Leonard, A. P., Ratnapriya, R., Ward, T., Pietraszkiewicz, A. A., O’Quinn, E. C., Adams, K., Swaroop, A., & Wolf, B. J. (2019) · PubMed Central · Cited by 26
Liu, Z., Qin, T., Zhou, J., Taylor, A., Sparrow, J. R., & Shang, F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_31 · Cited by 25
The past, present, and future of direct-to-consumer genetic tests
Helgason, A., & Stefánsson, K. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.1/ahelgason · Cited by 23
Rare genetic variants in Tunisian Jewish patients suffering from age-related macular degeneration
Pras, E., Kristal, D., Shoshany, N., Volodarsky, D., Vulih, I., Celniker, G., Isakov, O., Shomron, N., & Pras, E. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103130 · Cited by 28
Associations of Plasma-Soluble Fas Ligand with Aging and Age-Related Macular Degeneration
Jiang, S., Moriarty-Craige, S. E., Li, C., Lynn, M., Cai, J., Jones, D. P., & Sternberg, P. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0308 · Cited by 24
Genetics of Age-related Macular Degeneration
DeAngelis, M. M., & Ji, F. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50146-6 · Cited by 23
Nakata, I., Yamashiro, K., Akagi-Kurashige, Y., Miyake, M., Kumagai, K., Tsujikawa, A., Liu, K., Chen, L. J., Liu, D. T. L., Lai, T. Y. Y., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10219 · Cited by 23
Exploring the cross talk between ER stress and inflammation in age-related macular degeneration
Kheitan, S., Minuchehr, Z., & Soheili, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181667 · Cited by 22
What Does Genetics Tell Us About Age-Related Macular Degeneration?
Graßmann, F., Ach, T., Brandl, C., Heid, I. M., & Weber, B. H. F. (2015) · Annual Review of Vision Science · doi:10.1146/annurev-vision-082114-035609 · Cited by 24
CEP Biomarkers as Potential Tools for Monitoring Therapeutics
Renganathan, K., Gu, J., Rayborn, M. E., Crabb, J. S., Salomon, R. G., Collier, R. J., Kapin, M. A., Romano, C., Hollyfield, J. G., & Crabb, J. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076325 · Cited by 24
Metadata
- Authors
- The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., Barile, G. R., Smith, R. T., Hageman, G. S., Dean, M., & Allikmets, R.
- Affiliations
- National Cancer Institute (US)
- Columbia University (US)
- University of Iowa (US)
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Dean, Michael
- Allikmets, Rando
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-03-05
- Volume
- 38
- Issue
- 4
- Pages
- 458-462
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2921703
- OpenAlex
- W1997288094
- Cited by
- 1,075
- References
- 31
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 18 · 2023: 17 · 2022: 27 · 2021: 40 · 2020: 33 · 2019: 28 · 2018: 27 · 2017: 31 · 2016: 47 · 2015: 65 · 2014: 74 · 2013: 69 · 2012: 90
- FWCI
- 85.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Eye Institute (EY11515, R01EY013435, EY-13435, R01EY015520, R01EY011515)
- National Cancer Institute (N01-CO-124000)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, factor B, alternative complement pathway, genetic risk variants, haplotypes, complement factor H, MHC class III, genetic susceptibility
- MeSH terms
- Aged, Aged, 80 and over, Aging, Chromatography, High Pressure Liquid, Complement C2, Haplotypes, Humans, Immunohistochemistry, Macular Degeneration, Molecular Sequence Data, Complement Factor B, Cohort Studies, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.